Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$19.74−0.06 (-0.30%)
Close on Nov 17, 2026Market cap $999.81MP/E –Yield –
Cryoport operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cryoport's operating cash flow for the twelve months ending Jun 30, 2026 was $7.97M. For fiscal 2025 it was -$8.58M. The highest annual figure on record is $8.13M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.58M | – |
| FY2024 | Dec 31, 2024 | -$16.32M | – |
| FY2023 | Dec 31, 2023 | -$757.00K | – |
| FY2022 | Dec 31, 2022 | -$1.85M | -122.8% |
| FY2021 | Dec 31, 2021 | $8.13M | – |
| FY2020 | Dec 31, 2020 | -$14.87M | – |
| FY2019 | Dec 31, 2019 | -$1.32M | – |
| FY2018 | Dec 31, 2018 | -$3.35M | – |
| FY2016 | Mar 31, 2016 | -$6.31M | – |
| FY2015 | Mar 31, 2015 | -$4.13M | – |
| FY2014 | Mar 31, 2014 | -$4.38M | – |
| FY2013 | Mar 31, 2013 | -$4.79M | – |
| FY2012 | Mar 31, 2012 | -$6.78M | – |
| FY2011 | Mar 31, 2011 | -$4.81M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $1.13M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $3.74M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $919.00K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $2.19M | +389.5% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$7.35M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$4.34M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$5.48M | -320.8% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $447.00K | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$8.03M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$3.27M | -217.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $2.48M | -32.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$1.96M | -299.5% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$4.05M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $2.77M | +429.4% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $3.65M | +39.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $982.00K | -88.9% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$7.01M | -366.9% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $524.00K | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $2.61M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $8.88M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $2.63M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$5.99M | -665.7% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$9.71M | -1410.9% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$4.84M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$1.37M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $1.06M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $740.88K | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$813.40K | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.06M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$189.60K | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$359.41K | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$664.23K | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$1.27M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.06M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$1.97M | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$1.39M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$1.07M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$1.87M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -$1.29M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | -$1.06M | – |
See a number that looks wrong?